Version: Click here to use the Query Builder for Version 18.

Item Search:

CHAPTER VIII:

REQUIRED STATUS TABLE (ITEM # ORDER)

The following table presents Version 18 of the NAACCR required status summarizing the requirements and recommendations for collection of each item by standard-setting groups. Differences from Version 16 are marked “Revised” or “New” in the “Note” column of the table and are highlighted in the body of the table. Text of previous versions is revealed by hovering over a highlighted cell.

 

NPCR Refers to requirements and recommendations of the NPCR regarding data items that should be collected or computed by NPCR state registries. The NPCR transmit column in the Required Status Table has been removed with Version 11.2. Transmit instructions will be provided by NPCR. Note: Patient identifying data items collected are not transmitted to CDC.
CoC Refers to requirements of CoC. CoC-accredited cancer program registries are required to collect the indicated items in the “Collect” column and are required to report items indicated in the “Transmit” column to the NCDB. Facilities should refer to the CoC STORE manual for further clarification of required fields. Note: Patient identifying data items collected are not transmitted to the NCDB.
SEER Refers to requirements of NCI’s SEER Program. Central registries are required to collect the indicated items in the “Collect” column and are required to report the items indicated in the “Transmit” column to NCI-SEER. Facilities and central registries should refer to the SEER Program Code Manual for further clarification of required fields.
CCCR Refers to requirements of CCCR for cases submitted to the Canadian Cancer Registry. Provincial/Territorial registries should refer to the  Canadian Cancer Registry System Guide for further clarification of fields. Items indicated in the “Collect” column are required to be collected at the registry level and items indicated in the “Transmit” column are required to be reported to the Canadian Cancer Registry. CCCR requirements have been added to the Required Status Table with Version 11.2.

Exchange Elements for Hospital to Central and Central to Central

The target audience for this set of requirements is comprised of the various designers of registry software, at the hospital, central registry, and national levels. “T” is used when the data are vital to a complete exchange record. If a data item is unknown, it should have the proper code for unknown assigned. It is not specified how registries should handle records that have empty T fields. “T*” means the vendor should convey the data if they are available for any of the cases; otherwise, they can leave the field empty. The receiving end (central registry) may, of course, ignore these items if they so choose. “TH” means only certain historical cases may require these fields. Some central registries have additional required data fields. For these, vendors should contact the central registry directly.

Codes for Recommendations:

 

 . No recommendation
D Derived
D* Derived, when available
D+ Derived; central registries may collect either SEER Summary Stage 2000 or Collaborative Stage
DH  
Historically derived and currently transmitted
DH*
Historically derived and currently transmitted, when available
R Required
R# Required; central registries may code available data using either SEER or CoC data items and associated rules
R#* Required, when available; central registries may code available data using either SEER or CoC data items and associated rules
R$ Requirements differ by year
R* Required, when available
R^ Required, these text requirements may be met with one or several text block fields
R+ Required, central registries may collect either SEER Summary Stage 2000 or Collaborative Stage
RC Collected by SEER from CoC-accredited hospitals
RH Historically collected and currently transmitted
RH* Historically collected and currently transmitted when available
RN
Collect according to NPCR stage transition schedule                                                                                     
RS Required, site specific
RS# Required, site specific; central registries may code available data using either SEER or CoC data items and associated rules
RS* Required, site specific; when available
S Supplementary/recommended
T Data is vital to complete exchange record
T* Transmit data if available for any case in exchange record
TH Only certain historical cases may require these fields
TH* Only certain historical cases may require these fields; transmit data if available for any case in exchange record
Item #Item NameNPCRCoCSEERCCCRSource of StandardNote
CollectCollectTransmitCollectTransmitCollectTransmit
10Record TypeR.R.RRRNAACCR
20Patient ID NumberR..RRR*R*Reporting Registry
21Patient System ID-Hosp.......NAACCR
30Registry Type.......NAACCR
35FIN Coding SystemRetired
37Reserved 00
40Registry IDR..RRRRNAACCR
45NPI--Registry ID...R*...CMS
50NAACCR Record VersionR.RRR..NAACCR
60Tumor Record Number...SSR*R*NAACCR
70Addr at DX--CityRRRR.R*R*CoC
80Addr at DX--StateRRRRR..CoC
81State at DX Geocode 1970/80/90D..RR..NAACCRNew
82State at DX Geocode 2000D..RR..NAACCRNew
83State at DX Geocode 2010D..R*R*..NAACCRNew
84State at DX Geocode 2020D......NAACCRNew
89County at DX AnalysisD..RR..NAACCRNew
90County at DX ReportedRRRRR..FIPS/SEERRevised
94County at DX Geocode 1970/80/90D..DR..NAACCRRevised
95County at DX Geocode2000D..DR..NAACCR
96County at DX Geocode2010D..DR..NAACCR
97County at DX Geocode2020D......NAACCRRevised
100Addr at DX--Postal CodeRRRR.R*R*CoC
102Addr at DX--Country.RRR...NAACCR
110Census Tract 1970/80/90RH*..RHRH..SEER
120Census Cod Sys 1970/80/90RH*..RHRH..SEER
125Census Tract 2020D..R*R*..NAACCRNew
130Census Tract 2000RH..RHRH..NAACCR
135Census Tract 2010R..RR..NAACCR
140Census Tract Cod Sys--AltRetired
145Census Tr Poverty IndictrR..DR..NAACCR
150Marital Status at DX...RR..SEER
160Race 1RRRRR..SEER/CoC
161Race 2RRRRR..SEER/CoC
162Race 3RRRRR..SEER/CoC
163Race 4RRRRR..SEER/CoC
164Race 5RRRRR..SEER/CoC
170Race Coding Sys--Current.RR....NAACCR
180Race Coding Sys--Original.RR....NAACCR
190Spanish/Hispanic OriginRRRRR..SEER/CoC
191NHIA Derived Hisp OriginD..DR..NAACCR
192IHS LinkR*...R..NPCR
193Race--NAPIIA(derived API)R..DR..NAACCR
200Computed EthnicityR..DR..SEER
210Computed Ethnicity SourceR..RR..SEER
220SexRRRRRRRSEER/CoCRevised
230Age at DiagnosisRRRRRDDSEER/CoC
240Date of BirthRRRRRRRSEER/CoCRevised
241Date of Birth FlagRRRRR..NAACCRRevised
250BirthplaceRH*......SEER/CoCRevised
252Birthplace--StateR*RRRRRRNAACCRRevised
254Birthplace--CountryR*RRRRRRNAACCRRevised
260ReligionRetired
270Census Occ Code 1970-2000R*......Census/NPCR
272Census Ind Code 2010 CDCR*......Census/NPCR
280Census Ind Code 1970-2000R*......Census/NPCR
282Census Occ Code 2010 CDCR*......Census/NPCR
290Occupation SourceR*......NPCR
300Industry SourceR*......NPCR
310Text--Usual OccupationR*......NPCR
320Text--Usual IndustryR*......NPCR
330Census Occ/Ind Sys 70-00R*......NPCR
339RUCA 2000D..DR..NAACCRNew
340Tobacco HistoryRetired
341RUCA 2010D..DR..NAACCRNew
345URIC 2000D..DR..NAACCRNew
346URIC 2010D..DR..NAACCRNew
350Alcohol HistoryRetired
351GeoLocationID - 1970/80/90D..RR..NAACCRNew
352GeoLocationID - 2000D..RR..NAACCRNew
353GeoLocationID - 2010D..RR..NAACCRNew
354GeoLocationID - 2020D......NAACCRNew
360Family History of CancerRetired
361Census Block Group 2020.......CensusNew
362Census Block Group 2000...S...Census
363Census Block Group 2010...R...Census
364Census Tr Cert 1970/80/90RH*..RHRH..SEER
365Census Tr Certainty 2000RH..RHRH..NAACCR
366GIS Coordinate QualityR*..S...NAACCR
367Census Tr Certainty 2010R..RR..NAACCR
368Census Block Grp 1970/80/90...S...CensusRevised
369Census Tract Certainty 2020D......NAACCRNew
370Reserved 01
380Sequence Number--CentralR..RRDDSEER
390Date of DiagnosisRRRRRRR*SEER/CoC
391Date of Diagnosis FlagR..RR..NAACCR
400Primary SiteRRRRRRRSEER/CoC
410LateralityRRRRRRRSEER/CoCRevised
419Morph--Type&Behav ICD-O-2.......
420Histology (92-00) ICD-O-2RHRHRHRHRHRHRHSEER/CoC
430Behavior (92-00) ICD-O-2RHRHRHRHRHRHRHSEER/CoC
439Date of Mult Tumors Flag.RHRHRHRH..NAACCR
440GradeRHRHRHRHRHRHRHSEER/CoCRevised
441Grade Path ValueRH*RHRHRHRH..AJCC
442Ambiguous Terminology DX.RHRHRHRH..SEER
443Date Conclusive DX.RHRHRHRH..SEER
444Mult Tum Rpt as One Prim.RHRHRHRH..SEER
445Date of Mult Tumors.RHRHRHRH..SEER
446Multiplicity Counter.RHRHRHRH..SEER
447Number of Tumors/HistRetired
448Date Conclusive DX Flag.RHRHRHRH..NAACCR
449Grade Path SystemRH*RHRHRHRH..AJCC
450Site Coding Sys--CurrentRRR....NAACCR
460Site Coding Sys--Original.RR..R*R*NAACCR
470Morph Coding Sys--CurrentRRR....NAACCRRevised
480Morph Coding Sys--Originl.RR..R*R*NAACCR
490Diagnostic ConfirmationRRRRRRRSEER/CoC
500Type of Reporting SourceR..RR..SEER
501Casefinding SourceR*......NAACCR
510Screening DateRetired
520Screening ResultRetired
521Morph--Type&Behav ICD-O-3.......
522Histologic Type ICD-O-3RRRRRRRSEER/CoC
523Behavior Code ICD-O-3RRRRRRRSEER/CoC
530Reserved 02
538Reporting Hospital FANRetired
540Reporting FacilityRRRR...CoC
545NPI--Reporting FacilityR*RRR*...CMS
550Accession Number--Hosp.RRR...CoC
560Sequence Number--Hospital.RRR...CoC
570Abstracted By.RRR...CoC
580Date of 1st ContactRRR....CoC
581Date of 1st Contact FlagRRR....NAACCR
590Date of Inpt Adm.......NAACCR
591Date of Inpt Adm Flag.......NAACCR
600Date of Inpt Disch.......NAACCR
601Date of Inpt Disch Flag.......NAACCR
605Inpatient Status.......NAACCR
610Class of CaseRRRRC...CoC
620Year First Seen This CARetired
630Primary Payer at DXR*RRRR..CoC
640Inpatient/Outpt StatusRetired
650Presentation at CA ConfRetired
660Date of CA ConferenceRetired
665RX Hosp--ASA ClassRetired
668RX Hosp--Surg App 2010.RR....CoC
670RX Hosp--Surg Prim Site.RRR...CoC
672RX Hosp--Scope Reg LN Sur.RRR...CoC
674RX Hosp--Surg Oth Reg/Dis.RRR...CoC
676RX Hosp--Reg LN Removed.RHRH....CoC
678RX Hosp--Surg TimingRetired
680Reserved 03
682Date Regional Lymph Node Dissection.RRRCRC..NAACCRNew
683Date Regional Lymph Node Dissection Flag.RRRCRC..NAACCRNew
690RX Hosp--Radiation...RH...SEER
700RX Hosp--Chemo.RRR...CoC
710RX Hosp--Hormone.RRR...CoC
720RX Hosp--BRM.RRR...CoC
730RX Hosp--Other.RRR...CoC
740RX Hosp--DX/Stg Proc.RR....CoC
742RX Hosp--Screen/BX Proc1Retired
743RX Hosp--Screen/BX Proc2Retired
744RX Hosp--Screen/BX Proc3Retired
745RX Hosp--Screen/BX Proc4Retired
746RX Hosp--Surg Site 98-02.RHRHRH...CoC
747RX Hosp--Scope Reg 98-02.RHRHRH...CoC
748RX Hosp--Surg Oth 98-02.RHRHRH...CoC
750Reserved 04
752Tumor Size Clinical...RRR*R*SEERRevised
754Tumor Size Pathologic...RRR*R*SEERRevised
756Tumor Size SummaryRRRSS..NPCR/CoC
759SEER Summary Stage 2000RHRHRHRHRH..SEERRevised
760SEER Summary Stage 1977RHRHRH.S..SEER
762Derived Summary Stage 2018...DR..SEERRevised
764Summary Stage 2018RRRR*R*..SEERRevised
770Loc/Reg/Distant StageRetired
772EOD Primary Tumor...RR..SEERRevised
774EOD Regional Nodes...RR..SEERRevised
776EOD Mets...RR..SEERRevised
779Extent of Disease 10-Dig.......
780EOD--Tumor Size.RHRHRHRH..SEER/CoC
785Derived EOD 2018 T...DR..SEERNew
790EOD--Extension...RHRH..SEER
795Derived EOD 2018 M...DR..SEERNew
800EOD--Extension Prost Path...RHRH..SEER
810EOD--Lymph Node Involv...RHRH..SEER
815Derived EOD 2018 N...DR..SEERNew
818Derived EOD 2018 Stage Group...DR..SEERNew
820Regional Nodes PositiveRRRRRR*R*SEER/CoC
830Regional Nodes ExaminedRRRRRR*R*SEER/CoC
832Date of Sentinel Lymph Node Biopsy.RSRSR*R*..CoCNew
833Date of Sentinel Lymph Node Biopsy Flag.RSRSR*R*..CoCNew
834Sentinel Lymph Nodes Examined.RSRSR*R*..CoCNew
835Sentinel Lymph Nodes Positive.RSRSR*R*..CoCNew
840EOD--Old 13 Digit...RHRH..SEER
850EOD--Old 2 Digit...RHRH..SEER
860EOD--Old 4 Digit...RHRH..SEER
870Coding System for EOD...RHRH..SEER
880TNM Path TRHRHRHRHRH..AJCCRevised
890TNM Path NRHRHRHRHRH..AJCCRevised
900TNM Path MRHRHRHRHRH..AJCCRevised
910TNM Path Stage GroupRHRHRHRH*RH*..AJCCRevised
920TNM Path DescriptorRHRHRHRHRH..CoCRevised
930TNM Path Staged By.RHRHRHRH..CoCRevised
940TNM Clin TRHRHRHRHRH..AJCCRevised
950TNM Clin NRHRHRHRHRH..AJCCRevised
960TNM Clin MRHRHRHRHRH..AJCCRevised
970TNM Clin Stage GroupRHRHRHRH*RH*..AJCCRevised
980TNM Clin DescriptorRHRHRHRHRH..CoCRevised
990TNM Clin Staged By.RHRHRHRH..CoCRevised
995AJCC IDDDRRCRCR*R*NAACCRNew
1000TNM Other TRetired
1001AJCC TNM Clin T.RRRC.R*R*AJCCNew
1002AJCC TNM Clin N.RRRC.R*R*AJCCNew
1003AJCC TNM Clin M.RRRC.R*R*AJCCNew
1004AJCC TNM Clin Stage Group.RRRC.R*R*AJCCNew
1010TNM Other NRetired
1011AJCC TNM Path T.RRRC.R*R*AJCCNew
1012AJCC TNM Path N.RRRC.R*R*AJCCNew
1013AJCC TNM Path M.RRRC.R*R*AJCCNew
1014AJCC TNM Path Stage Group.RRRC.R*R*AJCCNew
1020TNM Other MRetired
1021AJCC TNM Post Therapy T.RRRC.R*R*AJCCNew
1022AJCC TNM Post Therapy N.RRRC.R*R*AJCCNew
1023AJCC TNM Post Therapy M.RRRC.R*R*AJCCNew
1024AJCC TNM Post Therapy Stage Group.RRRC.R*R*AJCCNew
1030TNM Other Stage GroupRetired
1031AJCC TNM Clin T Suffix.RRRC.R*R*AJCCNew
1032AJCC TNM Path T Suffix.RRRC.R*R*AJCCNew
1033AJCC TNM Post Therapy T Suffix.RRRC.R*R*AJCCNew
1034AJCC TNM Clin N Suffix.RRRC.R*R*AJCCNew
1035AJCC TNM Path N Suffix.RRRC.R*R*AJCCNew
1036AJCC TNM Post Therapy N Suffix.RRRC.R*R*AJCCNew
1040TNM Other Staged ByRetired
1050TNM Other DescriptorRetired
1060TNM Edition NumberRHRRRHRHRRCoCRevised
1070Other Staging SystemRetired
1080Date of 1st Positive BXRetired
1090Site of Distant Met 1Retired
1100Site of Distant Met 2Retired
1110Site of Distant Met 3Retired
1112Mets at DX-Bone.RRRRRRSEERRevised
1113Mets at DX-Brain.RRRRRRSEERRevised
1114Mets at Dx-Distant LN.RRRRRRSEERRevised
1115Mets at DX-Liver.RRRRRRSEERRevised
1116Mets at DX-Lung.RRRRRRSEERRevised
1117Mets at DX-Other.RRRRRRSEERRevised
1120Pediatric Stage.......CoC
1130Pediatric Staging System.......CoC
1140Pediatric Staged By.......CoC
1150Tumor Marker 1.RHRHRHRH..SEER
1160Tumor Marker 2.RHRHRHRH..SEER
1170Tumor Marker 3.RHRHRHRH..SEER
1180Reserved 05
1182Lymphovascular InvasionR*RRRSRSR*R*AJCCRevised
1190Reserved 06
1200RX Date SurgeryRRRRCRC..CoC
1201RX Date Surgery FlagRRRRCRC..NAACCR
1210RX Date RadiationRRRRCRC..CoC
1211RX Date Radiation FlagRRRRCRC..NAACCR
1220RX Date ChemoRRRRCRC..CoC
1221RX Date Chemo FlagRRRRCRC..NAACCR
1230RX Date HormoneRRRRCRC..CoC
1231RX Date Hormone FlagRRRRCRC..NAACCR
1240RX Date BRMRRRRCRC..CoC
1241RX Date BRM FlagRRRRCRC..NAACCR
1250RX Date OtherRRRRCRC..CoC
1251RX Date Other FlagRRRRCRC..NAACCR
1260Date Initial RX SEERR#..RR..SEER
1261Date Initial RX SEER FlagR#..RR..NAACCR
1270Date 1st Crs RX CoCR#RR....CoC
1271Date 1st Crs RX CoC FlagR#RR....NAACCR
1280RX Date DX/Stg Proc.RR....CoC
1281RX Date DX/Stg Proc Flag.RR....NAACCR
1285RX Summ--Treatment StatusR#RRRR..SEER/CoC
1290RX Summ--Surg Prim SiteRRRRR..SEER/CoC
1292RX Summ--Scope Reg LN SurRRRRR..SEER/CoC
1294RX Summ--Surg Oth Reg/DisRRRRR..SEER/CoC
1296RX Summ--Reg LN Examined.RHRHRHRH..SEER/CoC
1300Reserved 07
1310RX Summ--Surgical Approch.RHRH....CoC
1320RX Summ--Surgical Margins.RRR*R*..CoC
1330RX Summ--Reconstruct 1st.RHRHRHRH..SEER
1340Reason for No SurgeryRRRRR..SEER/CoC
1350RX Summ--DX/Stg Proc.RR....CoC
1360RX Summ--RadiationRH..RHRH..SEERRevised
1370RX Summ--Rad to CNS...RHRH..SEER/CoC
1380RX Summ--Surg/Rad SeqRRRRR..SEER/CoC
1390RX Summ--ChemoRRRRR..SEER/CoC
1400RX Summ--HormoneRRRRR..SEER/CoC
1410RX Summ--BRMRRRRR..SEER/CoC
1420RX Summ--OtherRRRRR..SEER/CoC
1430Reason for No RadiationRRRRR..CoCRevised
1440Reason for No ChemoRetired
1450Reason for No HormoneRetired
1460RX Coding System--CurrentRRR.RH..NAACCR
1470Protocol Eligibility StatRetired
1480Protocol ParticipationRetired
1490Referral to Support ServRetired
1500First Course Calc MethodRetired
1501Phase I Dose per Fraction.RRR*R*..CoCNew
1502Phase I Radiation External Beam Planning Tech.RRRCRC..CoCNew
1503Phase I Number of Fractions.RRR*R*..CoCNew
1504Phase I Radiation Primary Treatment Volume.RRR*R*..CoCNew
1505Phase I Radiation to Draining Lymph Nodes.RRR*R*..CoCNew
1506Phase I Radiation Treatment ModalityRRRRR..CoCNew
1507Phase I Total Dose.RRR*R*..CoCNew
1510Rad--Regional Dose: cGy.......CoCRevised
1511Phase II Dose per Fraction.RRR*R*..CoCNew
1512Phase II Radiation External Beam Planning Tech.RRRCRC..CoCNew
1513Phase II Number of Fractions.RRR*R*..CoCNew
1514Phase II Radiation Primary Treatment Volume.RRR*R*..CoCNew
1515Phase II Radiation to Draining Lymph Nodes.RRR*R*..CoCNew
1516Phase II Radiation Treatment Modality.RRRR..CoCNew
1517Phase II Total Dose.RRR*R*..CoCNew
1520Rad--No of Treatment Vol.......CoCRevised
1521Phase III Dose per Fraction.RRR*R*..CoCNew
1522Phase III Radiation External Beam Planning Tech.RRRCRC..CoCNew
1523Phase III Number of Fractions.RRR*R*..CoCNew
1524Phase III Radiation Primary Treatment Volume.RRR*R*..CoCNew
1525Phase III Radiation to Draining Lymph Nodes.RRR*R*..CoCNew
1526Phase III Radiation Treatment Modality.RRRR..CoCNew
1527Phase III Total Dose.RRR*R*..CoCNew
1530Rad--Elapsed RX DaysRetired
1531Radiation Treatment Discontinued Early.RRR*R*..CoCNew
1532Number of Phases of Rad Treatment to this Volume.RRR*R*..CoCNew
1533Total Dose.RRR*R*..CoCNew
1540Rad--Treatment Volume.......CoCRevised
1550Rad--Location of RX.RR....CoC
1560Rad--Intent of TreatmentRetired
1570Rad--Regional RX ModalityRH......CoCRevised
1580Rad--RX Completion StatusRetired
1590Rad--Local Control StatusRetired
1600Chemotherapy Field 1Retired
1610Chemotherapy Field 2Retired
1620Chemotherapy Field 3Retired
1630Chemotherapy Field 4Retired
1639RX Summ--Systemic/Sur SeqRRRRR..CoC
1640RX Summ--Surgery Type...RHRH..SEER
1642RX Summ--Screen/BX Proc1Retired
1643RX Summ--Screen/BX Proc2Retired
1644RX Summ--Screen/BX Proc3Retired
1645RX Summ--Screen/BX Proc4Retired
1646RX Summ--Surg Site 98-02.RHRHRHRH..SEER/CoC
1647RX Summ--Scope Reg 98-02.RHRHRHRH..SEER/CoC
1648RX Summ--Surg Oth 98-02.RHRHRHRH..SEER/CoC
1650Reserved 08
1660Subsq RX 2nd Course Date.......CoC
1661Subsq RX 2ndCrs Date Flag.......NAACCR
1670Subsq RX 2nd Course Codes.......
1671Subsq RX 2nd Course Surg.......CoC
1672Subsq RX 2nd Course Rad.......CoC
1673Subsq RX 2nd Course Chemo.......CoC
1674Subsq RX 2nd Course Horm.......CoC
1675Subsq RX 2nd Course BRM.......CoC
1676Subsq RX 2nd Course Oth.......CoC
1677Subsq RX 2nd--Scope LN SU.......CoC
1678Subsq RX 2nd--Surg Oth.......CoC
1679Subsq RX 2nd--Reg LN Rem.......CoC
1680Subsq RX 3rd Course Date.......CoC
1681Subsq RX 3rdCrs Date Flag.......NAACCR
1690Subsq RX 3rd Course Codes.......
1691Subsq RX 3rd Course Surg.......CoC
1692Subsq RX 3rd Course Rad.......CoC
1693Subsq RX 3rd Course Chemo.......CoC
1694Subsq RX 3rd Course Horm.......CoC
1695Subsq RX 3rd Course BRM.......CoC
1696Subsq RX 3rd Course Oth.......CoC
1697Subsq RX 3rd--Scope LN Su.......CoC
1698Subsq RX 3rd--Surg Oth.......CoC
1699Subsq RX 3rd--Reg LN Rem.......CoC
1700Subsq RX 4th Course Date.......CoC
1701Subsq RX 4thCrs Date Flag.......NAACCR
1710Subsq RX 4th Course Codes.......
1711Subsq RX 4th Course Surg.......CoC
1712Subsq RX 4th Course Rad.......CoC
1713Subsq RX 4th Course Chemo.......CoC
1714Subsq RX 4th Course Horm.......CoC
1715Subsq RX 4th Course BRM.......CoC
1716Subsq RX 4th Course Oth.......CoC
1717Subsq RX 4th--Scope LN Su.......CoC
1718Subsq RX 4th--Surg Oth.......CoC
1719Subsq RX 4th--Reg LN Rem.......CoC
1720Subsq RX 5th Course DateRetired
1730Subsq RX 5th Course CodesRetired
1731Subsq RX 5th Course SurgRetired
1732Subsq RX 5th Course RadRetired
1733Subsq RX 5th Course ChemoRetired
1734Subsq RX 5th Course HormRetired
1735Subsq RX 5th Course BRMRetired
1736Subsq RX 5th Course OthRetired
1737Subsq RX 5th--Scope LN SuRetired
1738Subsq RX 5th--Surg OthRetired
1739Subsq RX 5th--Reg LN RemRetired
1740Reserved 09
1741Subsq RX--Reconstruct Del.......CoC
1750Date of Last ContactRRRRR..SEER/CoC
1751Date of Last Contact FlagRRRRR..NAACCR
1755Date of Death--Canada.....R*R*CCCR
1756Date of Death--CanadaFlag.......NAACCRRevised
1760Vital StatusRRRRRDDSEER/CoC
1762Vital Status RecodeD..DR..NAACCRNew
1770Cancer Status.RR....CoC
1772Date of Last Cancer (tumor) Status .RR....CoCNew
1773Date of Last Cancer (tumor) Status FlagRR....CoCNew
1775Record Number Recode...DR..NAACCRNew
1780Quality of Survival.......CoC
1782Surv-Date Active Followup...DR..NAACCR
1783Surv-Flag Active Followup...DR..NAACCR
1784Surv-Mos Active Followup...DR..NAACCR
1785Surv-Date Presumed AliveD..DR..NAACCRRevised
1786Surv-Flag Presumed AliveD..DR..NAACCRRevised
1787Surv-Mos Presumed AliveD..DR..NAACCRRevised
1788Surv-Date DX RecodeD..DR..NAACCRRevised
1790Follow-Up SourceR*R.....CoC
1791Follow-up Source CentralR......NAACCR
1800Next Follow-Up Source.R.....CoC
1810Addr Current--City.R.R...CoC
1820Addr Current--State.R.R...CoC
1830Addr Current--Postal Code.R.R...CoC
1832Addr Current--Country.R.R...NAACCR
1835Reserved 10
1840County--Current.......NAACCR
1842Follow-Up Contact--City.......SEER
1844Follow-Up Contact--State.......SEER
1846Follow-Up Contact--Postal.......SEER
1847FollowUp Contact--Country.......NAACCR
1850Unusual Follow-Up Method.......NAACCR
1860Recurrence Date--1st.RRRC...CoC
1861Recurrence Date--1st Flag.RRRC...NAACCR
1870Recurrence Distant SitesRetired
1871Recurrence Distant Site 1Retired
1872Recurrence Distant Site 2Retired
1873Recurrence Distant Site 3Retired
1880Recurrence Type--1st.RRRC...CoC
1890Recurrence Type--1st--OthRetired
1900Reserved 11
1910Cause of DeathR..RRR*R*SEER
1914SEER Cause Specific CODD..DR..SEERNew
1915SEER Other CODD..DR..SEERNew
1920ICD Revision NumberR..RR..SEER
1930Autopsy.......NAACCR
1940Place of DeathRH....R*R*NPCR
1942Place of Death--StateR..RRDDNAACCRRevised
1944Place of Death--CountryR*..RRDDNAACCRRevised
1960Site (73-91) ICD-O-1...RHRH..SEER
1970Morph (73-91) ICD-O-1.......
1971Histology (73-91) ICD-O-1...RHRH..SEER
1972Behavior (73-91) ICD-O-1...RHRH..SEER
1973Grade (73-91) ICD-O-1...RHRH..SEER
1980ICD-O-2 Conversion Flag.RHRHRR..SEER
1981Over-ride SS/NodesPos...RHRH..NAACCRRevised
1982Over-ride SS/TNM-N...RHRH..NAACCRRevised
1983Over-ride SS/TNM-M...RHRH..NAACCRRevised
1984Over-ride SS/DisMet1Retired
1985Over-ride Acsn/Class/Seq.RR....CoC
1986Over-ride HospSeq/DxConf.RR....CoC
1987Over-ride CoC-Site/Type.RR....CoC
1988Over-ride HospSeq/Site.RR....CoC
1989Over-ride Site/TNM-StgGrpRRRRR..CoCRevised
1990Over-ride Age/Site/MorphRRRRR..SEER
1992Over-ride TNM StageR......NAACCRNew
1993Over-ride TNM TisR..RR..NAACCRNew
1994Over-ride TNM 3.......NAACCRNew
2000Over-ride SeqNo/DxConfR..RR..SEER
2010Over-ride Site/Lat/SeqNoR..RR..SEER
2020Over-ride Surg/DxConfRRRRR..SEER
2030Over-ride Site/TypeRRRRR..SEER
2040Over-ride HistologyRRRRR..SEER
2050Over-ride Report SourceR..RR..SEER
2060Over-ride Ill-define SiteR..RR..SEER
2070Over-ride Leuk, LymphomaRRRRR..SEER
2071Over-ride Site/BehaviorRRRRR..SEER
2072Over-ride Site/EOD/DX Dt...RR..SEER
2073Over-ride Site/Lat/EOD...RR..SEER
2074Over-ride Site/Lat/MorphRRRRR..SEER
2078Over-ride Name/SexR..RR..NAACCRNew
2080Reserved 13
2081CRC CHECKSUM...SS..NAACCR
2085Date Case Initiated.......NAACCR
2090Date Case Completed.......NAACCR
2092Date Case Completed--CoC.DD....CoC
2100Date Case Last Changed.DD....NAACCR
2110Date Case Report ExportedR......NPCR
2111Date Case Report ReceivedR......NPCR
2112Date Case Report LoadedR......NPCR
2113Date Tumor Record AvailblR......NPCR
2114Future Use Timeliness 1Retired
2115Future Use Timeliness 2Retired
2116ICD-O-3 Conversion FlagR..RR..SEER/CoC
2120SEER Coding Sys--Current....R..NAACCR
2130SEER Coding Sys--Original....R..NAACCR
2140CoC Coding Sys--Current.RR....CoC
2150CoC Coding Sys--Original.RR....CoC
2152CoC Accredited FlagR..RR..NPCRNew
2155RQRS NCDB Submission Flag.RR....CoCNew
2160Subsq Report for PrimaryRetired
2161Reserved 18Retired
2162Reserved 19Retired
2163Reserved 20Retired
2170Vendor Name.RR....NAACCR
2180SEER Type of Follow-Up...RR..SEER
2190SEER Record Number....R..SEER
2200Diagnostic Proc 73-87...RHRH..SEER
2210Reserved 14
2220State/Requestor Items.......Varies
2230Name--LastRR.R.RRCoCRevised
2240Name--FirstRR.R.R*R*CoC
2250Name--MiddleRR.R.R*R*CoC
2260Name--Prefix.......NAACCR
2270Name--Suffix...R...NAACCR
2280Name--AliasR..R...NAACCR
2290Name--Spouse/Parent.......NAACCR
2300Medical Record NumberRR.R...CoC
2310Military Record No Suffix.......CoC
2315Medicare Beneficiary IdentifierNAACCRNew
2320Social Security NumberRR.R...CoC
2330Addr at DX--No & StreetRR.R...CoC
2335Addr at DX--SupplementlRR*.R...CoC
2350Addr Current--No & Street.R.R...CoC
2352LatitudeR*..S...NAACCR
2354LongitudeR*..S...NAACCR
2355Addr Current--Supplementl.R*.R*...CoC
2360Telephone.R.R...CoC
2370DC StateRetired
2380DC State File NumberR..R*...State
2390Name--MaidenR..R.R*R*NAACCR
2392Follow-Up Contact--No&St.......SEER
2393Follow-Up Contact--Suppl.......SEER
2394Follow-Up Contact--Name.......SEER
2400Reserved 15
2410Institution Referred From.......CoC
2415NPI--Inst Referred From.R.....CMS
2420Institution Referred To.......CoC
2425NPI--Inst Referred To.R.....CMS
2430Last Follow-Up HospitalRetired
2440Following Registry...RH...CoC
2445NPI--Following Registry...RH*...CMS
2450Reserved 16
2460Physician--Managing.......NAACCR
2465NPI--Physician--Managing.R.....CMS
2470Physician--Follow-Up...R...CoC
2475NPI--Physician--Follow-Up.R.R*...CMS
2480Physician--Primary Surg.......CoC
2485NPI--Physician--Primary Surg.RR....CMS
2490Physician 3.......CoC
2495NPI--Physician 3.RR....CMS
2500Physician 4.......CoC
2505NPI--Physician 4.RR....CMS
2508EHR Reporting.......NAACCRNew
2510Reserved 12
2520Text--DX Proc--PER^..R...NPCR
2530Text--DX Proc--X-ray/ScanR^..R...NPCR
2540Text--DX Proc--ScopesR^..R...NPCR
2550Text--DX Proc--Lab TestsR^..R...NPCR
2560Text--DX Proc--OpR^..R...NPCR
2570Text--DX Proc--PathR^..R...NPCR
2580Text--Primary Site TitleR^..R...NPCR
2590Text--Histology TitleR^..R...NPCR
2600Text--StagingR^..R...NPCR
2610RX Text--SurgeryR^..R...NPCR
2620RX Text--Radiation (Beam)R^..R...NPCR
2630RX Text--Radiation OtherR^..R...NPCR
2640RX Text--ChemoR^..R...NPCR
2650RX Text--HormoneR^..R...NPCR
2660RX Text--BRMR^..R...NPCR
2670RX Text--OtherR^..R...NPCR
2680Text--Remarks...R...NPCR
2690Text--Place of Diagnosis.......NPCR
2700Reserved 17Retired
2730CS PreRx Tumor SizeRetired
2735CS PreRx ExtensionRetired
2740CS PreRx Tum Sz/Ext EvalRetired
2750CS PreRx Lymph NodesRetired
2755CS PreRx Reg Nodes EvalRetired
2760CS PreRx Mets at DXRetired
2765CS PreRx Mets EvalRetired
2770CS PostRx Tumor SizeRetired
2775CS PostRx ExtensionRetired
2780CS PostRx Lymph NodesRetired
2785CS PostRx Mets at DXRetired
2800CS Tumor SizeRH*RHRHRH*RH*RH*RH*AJCCRevised
2810CS ExtensionRH*RHRHRH*RH*RH*RH*AJCCRevised
2820CS Tumor Size/Ext EvalRH*RHRHRH*RH*RH*RH*AJCCRevised
2830CS Lymph NodesRH*RHRHRH*RH*RH*RH*AJCCRevised
2840CS Lymph Nodes EvalRH*RHRHRH*RH*RH*RH*AJCCRevised
2850CS Mets at DXRH*RHRHRH*RH*RH*RH*AJCCRevised
2851CS Mets at Dx-Bone.RHRHRHRHRH*RH*AJCCRevised
2852CS Mets at Dx-Brain.RHRHRHRHRH*RH*AJCCRevised
2853CS Mets at Dx-Liver.RHRHRHRHRH*RH*AJCCRevised
2854CS Mets at Dx-Lung.RHRHRHRHRH*RH*AJCCRevised
2860CS Mets EvalRH*RHRHRH*RH*RH*RH*AJCCRevised
2861CS Site-Specific Factor 7RH*RHRHRHRHRH*RH*AJCCRevised
2862CS Site-Specific Factor 8RH*RHRHRHRHRH*RH*AJCCRevised
2863CS Site-Specific Factor 9RH*RHRHRHRHRH*RH*AJCCRevised
2864CS Site-Specific Factor10RH*RHRHRHRHRH*RH*AJCCRevised
2865CS Site-Specific Factor11RH*RHRHRHRHRH*RH*AJCCRevised
2866CS Site-Specific Factor12RH*RHRHRHRHRH*RH*AJCCRevised
2867CS Site-Specific Factor13RH*RHRHRHRHRH*RH*AJCCRevised
2868CS Site-Specific Factor14RH*RHRHRHRHRH*RH*AJCCRevised
2869CS Site-Specific Factor15RH*RHRHRHRHRH*RH*AJCCRevised
2870CS Site-Specific Factor16RH*RHRHRHRHRH*RH*AJCCRevised
2871CS Site-Specific Factor17RH*RHRHRHRHRH*RH*AJCCRevised
2872CS Site-Specific Factor18.RHRHRHRHRH*RH*AJCCRevised
2873CS Site-Specific Factor19.RHRHRHRHRH*RH*AJCCRevised
2874CS Site-Specific Factor20.RHRHRHRHRH*RH*AJCCRevised
2875CS Site-Specific Factor21.RHRHRHRHRH*RH*AJCCRevised
2876CS Site-Specific Factor22.RHRHRHRHRH*RH*AJCCRevised
2877CS Site-Specific Factor23.RHRHRHRHRH*RH*AJCCRevised
2878CS Site-Specific Factor24.RHRHRHRHRH*RH*AJCCRevised
2879CS Site-Specific Factor25RH*RHRHRHRHRH*RH*AJCCRevised
2880CS Site-Specific Factor 1RH*RHRHRHRHRH*RH*AJCCRevised
2890CS Site-Specific Factor 2RH*RHRHRHRHRH*RH*AJCCRevised
2900CS Site-Specific Factor 3RH*RHRHRHRHRH*RH*AJCCRevised
2910CS Site-Specific Factor 4RH*RHRHRHRHRH*RH*AJCCRevised
2920CS Site-Specific Factor 5RH*RHRHRHRHRH*RH*AJCCRevised
2930CS Site-Specific Factor 6RH*RHRHRHRHRH*RH*AJCCRevised
2935CS Version Input OriginalR*RHRHRH*RH*RH*RH*AJCCRevised
2936CS Version DerivedRH*DHDHD*DH*DHDHAJCCRevised
2937CS Version Input CurrentR*RHRHRH*RH*RH*RH*AJCCRevised
2940Derived AJCC-6 T.DHDHDHRHDHDHAJCCRevised
2950Derived AJCC-6 T Descript.DHDHDHRHDHDHAJCCRevised
2960Derived AJCC-6 N.DHDHDHRHDHDHAJCCRevised
2970Derived AJCC-6 N Descript.DHDHDHRHDHDHAJCCRevised
2980Derived AJCC-6 M.DHDHDHRHDHDHAJCCRevised
2990Derived AJCC-6 M Descript.DHDHDHRHDHDHAJCCRevised
3000Derived AJCC-6 Stage Grp.DHDHDHRHDHDHAJCCRevised
3010Derived SS1977.DHDHD*SDHDHAJCCRevised
3020Derived SS2000RH*DHDHD+R+DHDHAJCCRevised
3030Derived AJCC--Flag.DHDHDHRH..AJCCRevised
3040Derived SS1977--Flag.DHDHD*S..AJCC
3050Derived SS2000--FlagRH*DHDHD*S..AJCCRevised
3100Archive FIN.RR....CoC
3105NPI--Archive FIN.RR....CMS
3110Comorbid/Complication 1.RHRH....CoCRevised
3120Comorbid/Complication 2.RHRH....CoCRevised
3130Comorbid/Complication 3.RHRH....CoCRevised
3140Comorbid/Complication 4.RHRH....CoCRevised
3150Comorbid/Complication 5.RHRH....CoCRevised
3160Comorbid/Complication 6.RHRH....CoCRevised
3161Comorbid/Complication 7.RHRH....CoCRevised
3162Comorbid/Complication 8.RHRH....CoCRevised
3163Comorbid/Complication 9.RHRH....CoCRevised
3164Comorbid/Complication 10.RHRH....CoCRevised
3165ICD Revision Comorbid.......CoC
3170RX Date Mst Defn SrgRRRRCRC..CoCRevised
3171RX Date Mst Defn Srg FlagRRRRCRC..NAACCRRevised
3180RX Date Surg Disch.RR....CoC
3181RX Date Surg Disch Flag.RR....NAACCR
3190Readm Same Hosp 30 Days.RR....CoC
3200Rad--Boost RX Modality.......CoCRevised
3210Rad--Boost Dose cGy.......CoCRevised
3220RX Date Rad Ended.RR....CoC
3221RX Date Rad Ended Flag.RR....NAACCR
3230RX Date Systemic.RRRCRC..CoC
3231RX Date Systemic Flag.RRRCRC..NAACCR
3250RX Summ--Transplnt/EndocrRRRRR..CoC
3260Pain AssessmentRetired
3270RX Summ--Palliative Proc.RR....CoC
3280RX Hosp--Palliative Proc.RR....CoC
3300RuralUrban Continuum 1993D......NAACCR
3310RuralUrban Continuum 2003D......NAACCR
3312RuralUrban Continuum 2013D..DR..NAACCR
3400Derived AJCC-7 TRH*DHDHDHRHDHDHAJCCRevised
3402Derived AJCC-7 T DescriptRH*DHDHDHRHDHDHAJCCRevised
3410Derived AJCC-7 NRH*DHDHDHRHDHDHAJCCRevised
3412Derived AJCC-7 N DescriptRH*DHDHDHRHDHDHAJCCRevised
3420Derived AJCC-7 MRH*DHDHDHRHDHDHAJCCRevised
3422Derived AJCC-7 M DescriptRH*DHDHDHRHDHDHAJCCRevised
3430Derived AJCC-7 Stage GrpRH*DHDHDHRHDHDHAJCCRevised
3440Derived PreRx-7 T.......AJCC
3442Derived PreRx-7 T Descrip.......AJCC
3450Derived PreRx-7 N.......AJCC
3452Derived PreRx-7 N Descrip.......AJCC
3460Derived PreRx-7 M.......AJCC
3462Derived PreRx-7 M Descrip.......AJCC
3470Derived PreRx-7 Stage Grp.......AJCC
3480Derived PostRx-7 T.......AJCC
3482Derived PostRx-7 N.......AJCC
3490Derived PostRx-7 M.......AJCC
3492Derived PostRx-7 Stge Grp.......AJCC
3600Derived Neoadjuv Rx Flag.......AJCC
3605Derived SEER Path Stg Grp...DHRH..SEERRevised
3610Derived SEER Clin Stg Grp...DHRH..SEERRevised
3614Derived SEER Cmb Stg Grp...DHRH..SEERRevised
3616Derived SEER Combined T...DHRH..SEERRevised
3618Derived SEER Combined N...DHRH..SEERRevised
3620Derived SEER Combined M...DHRH..SEERRevised
3622Derived SEER Cmb T Src...DHRH..SEERRevised
3624Derived SEER Cmb N Src...DHRH..SEERRevised
3626Derived SEER Cmb M Src...DHRH..SEERRevised
3645NPCR Derived AJCC 8 TNM Clin Stg Grp.....R*R*NPCRNew
3646NPCR Derived AJCC 8 TNM Path Stg Grp.....R*R*NPCRNew
3647NPCR Derived AJCC 8 TNM Post Therapy Stg Grp.....R*R*NPCRNew
3650NPCR Derived Clin Stg GrpRH......NPCRRevised
3655NPCR Derived Path Stg GrpRH......NPCRRevised
3700SEER Site-Specific Fact 1...RR..SEERRevised
3702SEER Site-Specific Fact 2.......SEER
3704SEER Site-Specific Fact 3.......SEER
3706SEER Site-Specific Fact 4.......SEER
3708SEER Site-Specific Fact 5.......SEER
3710SEER Site-Specific Fact 6.......SEER
3720NPCR Specific FieldR......NPCR
3750Over-ride CS 1.RHRH....AJCCRevised
3751Over-ride CS 2.RHRH....AJCCRevised
3752Over-ride CS 3.RHRH....AJCCRevised
3753Over-ride CS 4.RHRH....AJCCRevised
3754Over-ride CS 5.RHRH....AJCCRevised
3755Over-ride CS 6.RHRH....AJCCRevised
3756Over-ride CS 7.RHRH....AJCCRevised
3757Over-ride CS 8.RHRH....AJCCRevised
3758Over-ride CS 9.RHRH....AJCCRevised
3759Over-ride CS 10.RHRH....AJCCRevised
3760Over-ride CS 11.RHRH....AJCCRevised
3761Over-ride CS 12.RHRH....AJCCRevised
3762Over-ride CS 13.RHRH....AJCCRevised
3763Over-ride CS 14.RHRH....AJCCRevised
3764Over-ride CS 15.RHRH....AJCCRevised
3765Over-ride CS 16.RHRH....AJCCRevised
3766Over-ride CS 17.RHRH....AJCCRevised
3767Over-ride CS 18.RHRH....AJCCRevised
3768Over-ride CS 19.RHRH....AJCCRevised
3769Over-ride CS 20RHRHRHRHRH..AJCC/NPCRRevised
3780Secondary Diagnosis 1.RR....CoC
3782Secondary Diagnosis 2.RR....CoC
3784Secondary Diagnosis 3.RR....CoC
3786Secondary Diagnosis 4.RR....CoC
3788Secondary Diagnosis 5.RR....CoC
3790Secondary Diagnosis 6.RR....CoC
3792Secondary Diagnosis 7.RR....CoC
3794Secondary Diagnosis 8.RR....CoC
3796Secondary Diagnosis 9.RR....CoC
3798Secondary Diagnosis 10.RR....CoC
3800Schema IDDDRDRDRNAACCRNew
3801Chromosome 1p: Loss of Heterozygosity (LOH).RSRSRSRS..NAACCRNew
3802Chromosome 19q: Loss of Heterozygosity (LOH).RSRSRSRS..NAACCRNew
3803Adenoid Cystic Basaloid Pattern.RSRSRSRS..NAACCRNew
3804Adenopathy.RSRSRSRSRSRSNAACCRNew
3805AFP Post-Orchiectomy Lab Value.RSRSRCRC..NAACCRNew
3806AFP Post-Orchiectomy Range.RSRSRCRC..NAACCRNew
3807AFP Pre-Orchiectomy Lab Value.RSRSRCRC..NAACCRNew
3808AFP Pre-Orchiectomy Range.RSRSRCRC..NAACCRNew
3809AFP Pretreatment Interpretation.RSRSRCRCRSRSNAACCRNew
3810AFP Pretreatment Lab Value.RSRSRCRC..NAACCRNew
3811Anemia.RSRSRSRSRSRSNAACCRNew
3812B symptoms.RSRSRSRSRSRSNAACCRNew
3813Bilirubin Pretreatment Total Lab Value.RSRSRCRC..NAACCRNew
3814Bilirubin Pretreatment Unit of Measure.RSRSRCRC..NAACCRNew
3815Bone Invasion.RSRSRSRS..NAACCRNew
3816Brain Molecular MarkersR..RSRS..NAACCRNew
3817Breslow Tumor Thickness RRSRSRSRSRSRSNAACCRNew
3818CA-125 Pretreatment Interpretation.RSRSRSRSRSRSNAACCRNew
3819CEA Pretreatment Interpretation.RSRSRSRSRSRSNAACCRNew
3820CEA Pretreatment Lab Value.RSRSRSRS..NAACCRNew
3821Chromosome 3 Status.RSRSRCRC..NAACCRNew
3822Chromosome 8q Status.RSRSRCRC..NAACCRNew
3823Circumferential Resection Margin (CRM).RSRSRSRSRSRSNAACCRNew
3824Creatinine Pretreatment Lab Value.RSRSRCRC..NAACCRNew
3825Creatinine Pretreatment Unit of Measure.RSRSRCRC..NAACCRNew
3826Estrogen Receptor Percent Positive or Range .RSRSRCRC..NAACCRNew
3827Estrogen Receptor SummaryRRSRSRSRSRSRSNAACCRNew
3828Estrogen Receptor Total Allred Score RNRSRSRCRC..NAACCRNew
3829Esophagus and EGJ Tumor Epicenter.RSRSRSRSRSRSNAACCRNew
3830Extranodal Extension Clin (non-Head and Neck).RSRSRCRC..NAACCRNew
3831Extranodal Extension Head and Neck Clinical.RSRSRCRC..NAACCRNew
3832Extranodal Extension Head and Neck Pathological.RSRSRSRSRSRSNAACCRNew
3833Extranodal Extension Path (non-Head and Neck).RSRSRCRC..NAACCRNew
3834Extravascular Matrix Patterns .RSRSRCRC..NAACCRNew
3835Fibrosis ScoreRRSRSRCRC..NAACCRNew
3836FIGO Stage.RSRSRSRS..NAACCRNew
3837Gestational Trophoblastic Prognostic Scoring Index.RSRSRSRSRSRSNAACCRNew
3838Gleason Patterns Clinical.RSRSRSRSRSRSNAACCRNew
3839Gleason Patterns Pathological.RSRSRSRSRS*RS*NAACCRNew
3840Gleason Score Clinical.RSRSRCRCRSRSNAACCRNew
3841Gleason Score Pathological.RSRSRCRCRSRSNAACCRNew
3842Gleason Tertiary Pattern.RSRSRCRCRSRSNAACCRNew
3843Grade ClinicalRRRRRRRNAACCRNew
3844Grade PathologicalRNRRRRRRNAACCRNew
3845Grade Post TherapyRNRRRSRSRRNAACCRNew
3846hCG Post-Orchiectomy Lab Value.RSRSRCRC..NAACCRNew
3847hCG Post-Orchiectomy Range.RSRSRSRS..NAACCRNew
3848hCG Pre-Orchiectomy Lab Value.RSRSRCRC..NAACCRNew
3849hCG Pre-Orchiectomy Range.RSRSRSRS..NAACCRNew
3850HER2 IHC Summary .RSRSRS*RS*RSRSNAACCRNew
3851HER2 ISH Dual Probe Copy Number.RSRSRS*RS*..NAACCRNew
3852HER2 ISH Dual Probe Ratio.RSRSRS*RS*..NAACCRNew
3853HER2 ISH Single Probe Copy Number.RSRSRS*RS*..NAACCRNew
3854HER2 ISH Summary.RSRSRS*RS*RSRSNAACCRNew
3855HER2 Overall Summary RRSRSRSRSRSRSNAACCRNew
3856Heritable Trait.RSRSRSRSRSRSNAACCRNew
3857High Risk Cytogenetics.RSRSRSRSRSRSNAACCRNew
3858High Risk Histologic Features.RSRSRSRS..NAACCRNew
3859HIV Status.RSRSRSRS..NAACCRNew
3860International Normalized Ratio Prothrombin Time.RSRSRCRC..NAACCRNew
3861Ipsilateral Adrenal Gland Involvement.RSRSRSRS..NAACCRNew
3862JAK2.RSRSRSRS..NAACCRNew
3863Ki-67.RSRSRCRC..NAACCRNew
3864Invasion Beyond Capsule.RSRSRSRS..NAACCRNew
3865KIT Gene Immunohistochemistry .RSRSRCRCRSRSNAACCRNew
3866KRAS.RSRSRSRS..NAACCRNew
3867LDH Post-Orchiectomy Range.RSRSRSRS..NAACCRNew
3868LDH Pre-Orchiectomy Range.RSRSRSRS..NAACCRNew
3869LDH Pretreatment Level.RSRSRSRSRSRSNAACCRNew
3870LDH Upper Limits of Normal.RSRSRCRC..NAACCRNew
3871LN Assessment Method Femoral-Inguinal.RSRSRCRC..NAACCRNew
3872LN Assessment Method Para-Aortic.RSRSRCRC..NAACCRNew
3873LN Assessment Method Pelvic.RSRSRCRC..NAACCRNew
3874LN Distant Assessment Method.RSRSRCRC..NAACCRNew
3875LN Distant: Mediastinal, Scalene.RSRSRCRC..NAACCRNew
3876LN Head and Neck Levels I-III.RSRSRSRS..NAACCRNew
3877LN Head and Neck Levels IV-V.RSRSRSRS..NAACCRNew
3878LN Head and Neck Levels VI-VII.RSRSRSRS..NAACCRNew
3879LN Head and Neck Other.RSRSRSRS..NAACCRNew
3880LN Isolated Tumor Cells (ITC).RSRSRSRS..NAACCRNew
3881LN Laterality.RSRSRSRS..NAACCRNew
3882LN Positive Axillary Level I-II.RSRSRSRS..NAACCRNew
3883LN Size.RSRSRSRSRSRSNAACCRNew
3884LN Status Femoral-Inguinal, Para-Aortic, Pelvic.RSRSRSRS..NAACCRNew
3885Lymphocytosis.RSRSRSRSRSRSNAACCRNew
3886Major Vein Involvement.RSRSRSRS..NAACCRNew
3887Measured Basal Diameter.RSRSRSRS..NAACCRNew
3888Measured Thickness.RSRSRSRS..NAACCRNew
3889Methylation of O6-Methylguanine-Methyltransferase.RSRSRSRS..NAACCRNew
3890Microsatellite Instability (MSI)RS*RSRSRSRSRSRSNAACCRNew
3891Microvascular Density .RSRSRCRC..NAACCRNew
3892Mitotic Count Uveal Melanoma.RSRSRCRC..NAACCRNew
3893Mitotic Rate Melanoma.RSRSRSRSRSRSNAACCRNew
3894Multigene Signature Method.RSRSRSRS..NAACCRNew
3895Multigene Signature Results.RSRSRSRS..NAACCRNew
3896NCCN International Prognostic Index (IPI).RSRSRSRS..NAACCRNew
3897Number of Cores Examined.RSRSRSRSRSRSNAACCRNew
3898Number of Cores Positive.RSRSRSRSRSRSNAACCRNew
3899Number of Examined Para-Aortic Nodes.RSRSRCRC..NAACCRNew
3900Number of Examined Pelvic Nodes.RSRSRCRC..NAACCRNew
3901Number of Positive Para-Aortic Nodes.RSRSRCRC..NAACCRNew
3902Number of Positive Pelvic Nodes.RSRSRCRC..NAACCRNew
3903Oncotype Dx Recurrence Score-DCIS.RSRSRCRC..NAACCRNew
3904Oncotype Dx Recurrence Score-Invasive.RSRSRSRSRSRSNAACCRNew
3905Oncotype Dx Risk Level-DCIS.RSRSRCRC..NAACCRNew
3906Oncotype Dx Risk Level-Invasive.RSRSRCRC..NAACCRNew
3907Organomegaly.RSRSRSRSRSRSNAACCRNew
3908Percent Necrosis Post Neoadjuvant.RSRSRCRCRSRSNAACCRNew
3909Perineural Invasion.RSRSRSRS..NAACCRNew
3910Peripheral Blood Involvement.RSRSRSRSRSRSNAACCRNew
3911Peritoneal Cytology.RSRSRSRS..NAACCRNew
3913Pleural Effusion.RSRSRSRS..NAACCRNew
3914Progesterone Receptor Percent Positive or Range.RSRSRCRC..NAACCRNew
3915Progesterone Receptor SummaryRRSRSRSRSRSRSNAACCRNew
3916Progesterone Receptor Total Allred ScoreRNRSRSRCRC..NAACCRNew
3917Primary Sclerosing Cholangitis .RSRSRCRC..NAACCRNew
3918Profound Immune Suppression.RSRSRSRS..NAACCRNew
3919Prostate Pathological Extension.RSRSRSRS..NAACCRNew
3920PSA (Prostatic Specific Antigen) Lab ValueRRSRSRSRSRSRSNAACCRNew
3921Residual Tumor Volume Post Cytoreduction .RSRSRSRS..NAACCRNew
3922Response to Neoadjuvant Therapy.RSRSRCRC..NAACCRNew
3923S Category Clinical.RSRSRSRSRSRSNAACCRNew
3924S Category Pathological.RSRSRSRSRSRSNAACCRNew
3925Sarcomatoid Features.RSRSRSRS..NAACCRNew
3926Schema Discriminator 1RRSRSRSRSRSRSNAACCRNew
3927Schema Discriminator 2RRSRSRSRSRSRSNAACCRNew
3928Schema Discriminator 3.RSRSRSRSRSRSNAACCRNew
3929Separate Tumor Nodules.RSRSRSRS..NAACCRNew
3930Serum Albumin Pretreatment Level.RSRSRSRSRSRSNAACCRNew
3931Serum Beta-2 Microglobulin Pretreatment Level.RSRSRSRSRSRSNAACCRNew
3932LDH Pretreatment Lab ValueRRSRSRSRS..NAACCRNew
3933Thrombocytopenia.RSRSRSRSRSRSNAACCRNew
3934Tumor Deposits.RSRSRSRS..NAACCRNew
3935Tumor Growth Pattern.RSRSRSRS..NAACCRNew
3936Ulceration.RSRSRSRSRSRSNAACCRNew
3937Visceral and Parietal Pleural Invasion.RSRSRSRS..NAACCRNew
7010Path Reporting Fac ID 1.......HL7
7011Path Reporting Fac ID 2.......HL7
7012Path Reporting Fac ID 3.......HL7
7013Path Reporting Fac ID 4.......HL7
7014Path Reporting Fac ID 5.......HL7
7090Path Report Number 1.......HL7
7091Path Report Number 2.......HL7
7092Path Report Number 3.......HL7
7093Path Report Number 4.......HL7
7094Path Report Number 5.......HL7
7100Path Order Phys Lic No 1.......HL7
7101Path Order Phys Lic No 2.......HL7
7102Path Order Phys Lic No 3.......HL7
7103Path Order Phys Lic No 4.......HL7
7104Path Order Phys Lic No 5.......HL7
7190Path Ordering Fac No 1.......HL7
7191Path Ordering Fac No 2.......HL7
7192Path Ordering Fac No 3.......HL7
7193Path Ordering Fac No 4.......HL7
7194Path Ordering Fac No 5.......HL7
7320Path Date Spec Collect 1.......HL7
7321Path Date Spec Collect 2.......HL7
7322Path Date Spec Collect 3.......HL7
7323Path Date Spec Collect 4.......HL7
7324Path Date Spec Collect 5.......HL7
7480Path Report Type 1.......HL7
7481Path Report Type 2.......HL7
7482Path Report Type 3.......HL7
7483Path Report Type 4.......HL7
7484Path Report Type 5.......HL7